Novel compositons and methods for treating IgE-mediated disorders

Details for Australian Patent Application No. 2009293143 (hide)

Owner Xencor, Inc.

Inventors Desjarlais, John R.; Chu, Seung Y.; Horton, Holly M.

Agent Davies Collison Cave

Pub. Number AU-A-2009293143

PCT Pub. Number WO2010/033736

Priority 61/097,819 17.09.08 US

Filing date 17 September 2009

Wipo publication date 25 March 2010

International Classifications

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/033736 Priority application(s): WO2010/033736

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009293156-Apparatus for and method of mounting and locking devices to conveyor belt systems

2009293140-Folate receptor binding conjugates of antifolates